The Latest

This Week in HIV Research: One Step at a Time

June 13, 2019: Integrated stepped alcohol treatment in HIV clinics; cytokines, inflammation, and heart risk; impact of CCR5 gene editing on lifespan; the costs of "test and treat" for hepatitis C.

By Barbara Jungwirth and Myles Helfand

Antiviral Stewardship Program Reduces Medication Errors at a Veterans Affairs Hospital

When people living with HIV are admitted to a hospital, they may not be able to bring their medications with them, and could be prescribed new medication by a doctor who doesn't understand their complete medical history.

By Sony Salzman

This Week in HIV Research: Additional Nuance on Pregnancy and Antiretrovirals

Switching HIV treatment regimens during the first trimester; drivers of viral breakthrough during pregnancy; HIV’s effect on liver risk after hepatitis C treatment; hepatic steatosis among young people with HIV.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Getting Smart(Phone) About HIV Detection

A cellphone attachment that detects HIV RNA; HIV-2 does indeed often progress to AIDS; CD4 count declines and incident hepatitis C coinfection; the global demographics of non-Hodgkin lymphoma.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Where Support Is Lacking, the Virus Can Spread

Housing, social support, and HIV transmissibility among people who use drugs; concerning hepatitis C incidence trends in France; frailty among people aging with HIV; untreated HIV and brain atrophy.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: When Prioritizing Treatment, Look Beyond CD4

Gauging treatment priority when CD4 count is high; the effect of hepatitis C coinfection on response to HIV treatment; HIV, aging and comorbidity in Africa; PrEP and drug-resistant gonorrhea.

By Barbara Jungwirth and Myles Helfand

Hepatitis C and HIV Each Linked to Artery Plaque Buildup in Gay Men

Hepatitis C (HCV) and HIV infection were independently associated with markers of subclinical atherosclerosis -- including plaque and coronary artery calcium -- in a study of 994 men who have sex with men.

By Mark Mascolini

African-American Women With HIV/HCV Less Likely to Die From Liver Disease

University of California San Francisco (UCSF) researchers have found that among women co-infected with HIV and hepatitis C virus (HCV), African Americans were less likely to die of liver disease. Of nearly 800 women enrolled in the Women's Interagenc...

By Enid Vazquez for Positively Aware

Top 10 HIV/AIDS-Related Clinical Developments of 2011

David Wohl, M.D., takes an in-depth look at this year's most critical HIV-related studies, and explains how each one may change how we prevent and treat HIV in 2012 and beyond. (Fair warning: This article can get pretty technical, but each story has ...

By David Alain Wohl, M.D.

U.S., EU Grant Accelerated Reviews of Merck Hepatitis Drug

The U.S. Food and Drug Administration (FDA) has granted an accelerated review of Merck & Co.'s experimental hepatitis C drug boceprevir, a status designated for drugs that represent a significant medical advancement or address a public health need.

...

By CDC National Prevention Information Network